STS Globalome & Growth Trust (CHIX:STSL) Revenue: £-10.37 Mil (TTM As of Mar. 2026)


CHIX:STSL STS Global Income & Growth Trust PLC CHIX:STSL
61 GF Score
Price £2.33
GF Value £3.07
! 2 Warning Signs
View Full Analysis

What is STS Globalome & Growth Trust Revenue?

STS Globalome & Growth Trust CHIX:STSL 61 Revenue is £-10.37 Mil as of Mar. 2026. GuruFocus rates CHIX:STSL with a GF Score™ of 61/100 and a GF Value™ of £3.07. The stock has 2 warning signs investors should review.

STS Globalome & Growth Trust's revenue for the six months ended in Mar. 2026 was £-16.38 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was £-10.37 Mil. STS Globalome & Growth Trust's Revenue per Share for the six months ended in Mar. 2026 was £-0.14. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was £-0.09.

Warning Sign:

STS Global Income & Growth Trust PLC revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of STS Globalome & Growth Trust was -135.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -40.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, STS Globalome & Growth Trust's highest 3-Year average Revenue per Share Growth Rate was 93.50% per year. The lowest was -40.10% per year. And the median was 4.75% per year.


STS Globalome & Growth Trust  (CHIX:STSl) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


STS Globalome & Growth Trust Revenue Related Terms


STS Globalome & Growth Trust Revenue Historical Data

* Premium members only.

The historical data trend for STS Globalome & Growth Trust's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

STS Globalome & Growth Trust Revenue Chart

STS Globalome & Growth Trust Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.09 -3.17 11.53 31.48 -10.37

STS Globalome & Growth Trust Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.73 11.33 20.15 6.01 -16.38

CHIX:STSL vs BLK, BX, KKR: Revenue Comparison

For the Asset Management subindustry, STS Globalome & Growth Trust's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


STS Globalome & Growth Trust Revenue vs Asset Management Industry

For the Asset Management industry and Financial Services sector, STS Globalome & Growth Trust's Revenue distribution charts can be found below:

* The bar in red indicates where STS Globalome & Growth Trust's Revenue falls into.


CHIX:STSL
61GF Score
STS Global Income & Growth Trust PLC CHIX:STSL
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

STS Globalome & Growth Trust Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-10.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of £-10.37 Mil mean?
STS Globalome & Growth Trust (CHIX:STSL) has a Revenue of £-10.37 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on STS Globalome & Growth Trust and its competitors.
Is STS Globalome & Growth Trust's Revenue too high?
STS Globalome & Growth Trust's current Revenue is £-10.37 Mil. Overall, STS Globalome & Growth Trust has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does STS Globalome & Growth Trust's Revenue compare to BLK and BX?
STS Globalome & Growth Trust's Revenue of £-10.37 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Asset Management company?
A good Revenue depends on the Asset Management industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on STS Globalome & Growth Trust and its competitors. STS Globalome & Growth Trust's current Revenue is £-10.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is STS Globalome & Growth Trust stock overvalued right now?
STS Globalome & Growth Trust (CHIX:STSL) has a current Revenue of £-10.37 Mil. The stock's GF Value™ is £3.07, compared to a current price of £2.33 — trading 24.1% below its estimated fair value. The current Revenue is £-10.37 Mil. STS Globalome & Growth Trust's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For STS Globalome & Growth Trust (CHIX:STSL), the current Revenue is £-10.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is STS Globalome & Growth Trust (CHIX:STSL) Overvalued in 2026?

Based on GuruFocus' analysis, STS Globalome & Growth Trust stock appears to be undervalued. The current stock price of £2.33 is trading 24.1% below its estimated GF Value™ of £3.07.

Key valuation signals for CHIX:STSL:

  • Revenue: £-10.37 Mil
  • GF Value™: £3.07 vs. price of £2.33 (24.1% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the CHIX:STSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


STS Globalome & Growth Trust Business Description

Other Exchanges STS:UK
Address 28 Walker Street, Edinburgh, GBR, EH3 7HR
STS Global Income & Growth Trust PLC is an investment trust, is a UK closed-end public limited company that invests in a diversified portfolio of assets meeting certain tax conditions. Its objective is to deliver rising income and long-term capital growth through investment in a balanced portfolio constructed from various countries' equities. The company invests in Financials, Information technology, Industrials, Consumer staples, Consumer discretionary, Healthcare, Real estate and Communication services sectors. It has a presence in North America, Europe, and the Asia.
61GF Score

Get the complete analysis for CHIX:STSL

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.33
Price
£3.07
GF Value